| Literature DB >> 26407811 |
Yusuke Okuno1, Akihiro Hoshino2, Hideki Muramatsu1, Nozomu Kawashima1, Xinan Wang1, Kenichi Yoshida3, Taizo Wada4, Masaharu Gunji5, Tomoko Toma4, Tamaki Kato6, Yuichi Shiraishi7, Atsuko Iwata8, Toshinori Hori8, Toshiyuki Kitoh8, Kenichi Chiba7, Hiroko Tanaka7, Masashi Sanada3, Yoshiyuki Takahashi1, Shigeaki Nonoyama6, Masafumi Ito5, Satoru Miyano7,9, Seishi Ogawa3, Seiji Kojima1, Hirokazu Kanegane10,11.
Abstract
Primary immunodeficiency disease (PID) is caused by mutations of more than two hundred immunity-related genes. In addition to the heterogeneity of the diseases, the atypical presentation of each disease caused by hypomorphic mutations or somatic mosaicism makes genetic diagnosis challenging. Next-generation sequencing tests all genes simultaneously and has proven its innovative efficacy in genomics. We describe a male PID patient without any family history of immunodeficiency. This patient suffered from recurrent infections from 1 year of age. Laboratory analysis showed hypogammaglobulinemia. T, B, and NK cells were present, but the T cell proliferative response decreased. Whole-exome sequencing analysis identified an IL2RG p.P58T missense mutation. CD8(+) and CD56(+) cells showed revertant somatic mosaicism to the wild-type allele. A late-onset and atypical presentation of the X-linked severe combined immunodeficiency (X-SCID) phenotype might be associated with revertant somatic mosaicism in T and NK cells. This patient is the seventh reported case of X-SCID with revertant somatic mosaicism. His classical clinical management did not result in a molecular diagnosis because of the atypical presentation. The coverage that is provided by whole-exome sequencing of most PID genes effectively excluded differential diagnoses other than X-SCID. As next-generation sequencing becomes available in clinical practice, it will enhance our knowledge of PID and rescue currently undiagnosed patients.Entities:
Keywords: Combined immunodeficiency; Revertant somatic mosaicism; Whole-exome sequencing; X-linked severe combined immunodeficiency
Mesh:
Substances:
Year: 2015 PMID: 26407811 DOI: 10.1007/s10875-015-0202-0
Source DB: PubMed Journal: J Clin Immunol ISSN: 0271-9142 Impact factor: 8.317